Literature DB >> 19248726

Genetically determined neuromuscular disorders of some Roma families living in Hungary.

Laszlo Aranka1, Mayer Peter, Kobor Jeno, Racz Katalin, Talosi Gyula, Endreffy Emoke, Herczegfalvi Agnes, Hortobagyi Tibor, Tiszlavicz Laszlo, Bereg Edit, Katona Marta, Szabo Janos, Karcagi Veronika.   

Abstract

The authors discuss the clinical and molecular genetic aspects of genetically determined neuromuscular disorders of some Roma families living in Hungary. Among the autosomal recessively inherited spinal muscular atrophic (SMA) group, 8 Caucasian children had the typical 7-8 exonal deletions of the SMA gene, but only 2 patients belonged to the Roma population. There was no difference in the molecular genetic findings among the Caucasian and the Roma SMA patients. All of them had 7-8 exonal deletions of the SMA gene. We wanted to call attention to the founder mutation of the Roma population in 7 patients suffering from congenital myasthenia (CMS) from 3 Roma families. The 1267G deletion for CMS was detected by molecular genetic method. Clinical onset was pubertal and relatively slow progression of specific and phenotypic features for this founder mutation of acetyl-cholin receptor epsylon gene. In 2 patients (sister and brother) the sarcoglycanopathy 2C type C283Q mutation was proven in one Roma family suffering from limb-girdle muscular dystrophy (LGMD). Two out of the three facioscapular-humeral dystrophy (FSHD) Roma families carried 21.8 kb and 18.5 kb alleles in FSHD A1 gene (D4S139). In one family together with prenatal diagnosis founder mutation in FSHD A1 gene was detected, according to the autosomal dominant (AD) inheritance. In (F2) prenatal diagnosis was carried out, 18.5 kb/18.5 kb homozygosity was proven in the fetus, so the pregnancy was interrupted. In the CMS, LGMD and FSHD Roma patients ancient typical Roma founder mutations were found.

Entities:  

Mesh:

Year:  2009        PMID: 19248726

Source DB:  PubMed          Journal:  Ideggyogy Sz        ISSN: 0019-1442            Impact factor:   0.427


  2 in total

1.  The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.

Authors:  Emese Juhász; Judit Béres; Szilvia Kanizsai; Károly Nagy
Journal:  Pathol Oncol Res       Date:  2011-06-11       Impact factor: 3.201

Review 2.  Research advancement in immunopathogenesis of myasthenia gravis.

Authors:  Sha Huang; Li-Ming Tan
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.